Harbour Investments’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$511K Buy
3,026
+508
+20% +$86.9K 0.01% 1049
2025
Q4
$425K Buy
2,518
+387
+18% +$62.9K 0.01% 924
2025
Q3
$308K Buy
2,131
+531
+33% +$72.5K 0.01% 1045
2025
Q2
$202K Sell
1,600
-252
-14% -$30.9K 0.01% 1168
2025
Q1
$237K Sell
1,852
-120
-6% -$16.3K 0.01% 1023
2024
Q4
$261K Buy
1,972
+465
+31% +$65.4K 0.01% 925
2024
Q3
$219K Sell
1,507
-542
-26% -$78.4K 0.01% 978
2024
Q2
$281K Sell
2,049
-18
-0.9% -$2.4K 0.01% 816
2024
Q1
$284K Sell
2,067
-554
-21% -$75.7K 0.01% 787
2023
Q4
$356K Buy
2,621
+1,011
+63% +$123K 0.01% 657
2023
Q3
$197K Sell
1,610
-316
-16% -$40.2K 0.01% 797
2023
Q2
$245K Buy
1,926
+19
+1% +$2.47K 0.01% 723
2023
Q1
$246K Sell
1,907
-226
-11% -$29.6K 0.01% 694
2022
Q4
$280K Buy
2,133
+409
+24% +$52.9K 0.02% 621
2022
Q3
$203K Hold
1,724
0.01% 683
2022
Q2
$203K Buy
+1,724
New +$205K 0.01% 683
2021
Q4
$276K Sell
1,809
-2,768
-60% -$429K 0.02% 600
2021
Q3
$740K Buy
4,577
+20
+0.4% +$3.37K 0.02% 518
2021
Q2
$746K Sell
4,557
-5,879
-56% -$906K 0.02% 525
2021
Q1
$1.57M Buy
+10,436
New +$1.66M 0.06% 300

Other funds holding IBB

Harbour Investments's IBB Position: Q1 2026 in Review

Harbour Investments increased its iShares Biotechnology ETF (IBB) stake by 20% in Q1 2026, buying an estimated $86.9K and bringing the position to 3,026 shares worth $511K. The position accounts for 0.01% of the portfolio, ranked #1049.

Harbour Investments first reported a position in IBB in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.57M in Q1 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Harbour Investments held 3,026 shares of iShares Biotechnology ETF worth $511K as of Q1 2026.
  • Harbour Investments bought 508 iShares Biotechnology ETF shares in Q1 2026, an estimated $86.9K.
  • iShares Biotechnology ETF made up 0.01% of Harbour Investments's portfolio in Q1 2026, its #1049 holding.
  • Harbour Investments first reported a position in iShares Biotechnology ETF in Q1 2021 and has held it in 20 quarters since.
  • Harbour Investments's iShares Biotechnology ETF position peaked at $1.57M in Q1 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.